Abstract

The treatment of asthma aims to keep the airways as normal as possible. They become narrowed because of mucosal inflammation and contraction of bronchial muscle. This mucosal inflammation is present even in the absence of symptoms,1 and probably causes the bronchial hyperreactivity so characteristic of asthma.2 If it is not treated adequately, the narrowing of the airways may become permanent.3 Bronchodilators treat symptoms but have no effect on the underlying inflammation. The early use of anti-inflammatory drugs might reverse this sequence, although there is no direct evidence that it alters the natural history of the disease.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.